Lectenz Bio in News and Media

January 11, 2023 0 0

Lectenz Bio’s paper, “Simplifying the detection and monitoring of protein glycosylation during in vitro glycoengineering,” has...

December 1, 2022 0 0

Cedarlane is now distributing Lectenz Bio products for Canadian customers. We are excited to have Cedarlane listing our catalog and look forward...

November 1, 2022 0 0

Lectenz Bio has recently signed a distribution agreement with MBL Beijing Biotech Co., Ltd., a Chinese life science distributor. This agreement...

June 9, 2022 0 0

Lectenz Bio has recently signed a distribution agreement with Scientist.com, a U.S. life science distributor. This agreement will allow...

May 4, 2022 0 0

Lectenz Bio was excited to have CEO Lori Yang and VP of R&D Sean Wu present at the Common Fund GlycoScience Program!

February 28, 2022 0 0

Lectenz Bio was proud to be a sponsor of the 2022 Rare Disease Day Symposium & CDG/NGLY1 Family Conference! It’s always exciting to see...

February 4, 2022 0 0

Lectenz Bio has recently signed a distribution agreement with Krishgen Biosystems, an Indian life science distributor. This agreement will allow...

December 6, 2021 0 0

Lectenz Bio has recently signed a distribution agreement with Advion Interchim, a French life science distributor. This agreement will allow...

November 16, 2021 0 0

Lectenz Bio attended and sponsored the Society for Glycobiology 2021 Annual Meeting in San Diego. Dr. Shaza Abnouf and Christian Gerner-Smidt...

August 25, 2021 0 0

Lectenz Bio has recently signed a distribution agreement with Hölzel Diagnostika, a life sciences distributor. This agreement will allow Hölzel...

January 25, 2021 0 0

Lectenz Bio has recently signed a distribution agreement with 2B Scientific, a life sciences distributor. This agreement will allow 2B Scientific...

January 15, 2021 0 0

We are excited to announce Dr. Sean Wu as our new Vice President of Research and Development. A veteran team member, Dr. Wu has worked at Lectenz...